The first stage of the Phase IIa study with YELIVA® for advanced cholangiocarcinoma (bile ...
WASHINGTON, Sept. 17, 2015 (GLOBE NEWSWIRE) -- The Campaign to Change Direction, a national ...
WATERTOWN, Mass., March 29, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider ...
